Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rice-derived Recombinant Human Serum Albumin for Hypoalbuminemia After Hepatectomy
NCT07634549Phase 4Recruiting
- Sponsor
- Chengqi Biotech
- Start
- Jun 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
A Phase 4 trial of recombinant human serum albumin in hypoalbuminemia, sponsored by Chengqi Biotech. Started Jun 2026; status: recruiting.
02
Drugs
recombinant human serum albumin
03
Conditions
hypoalbuminemia
Beyond the preview
Go deeper on NCT07634549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07634549.